E-LIB Suche - Ergebnisse für: Soelberg Sorensen, Per

1

Age-corrected neurofilament light chain ratio decreases but..:

Højsgaard Chow, Helene ; Petersen, Eva Rosa ; Olsson, Anna...
Multiple Sclerosis and Related Disorders. 88 (2024) - p. 105701 , 2024

Link: https://doi.org/10.1016/..

2

Population Pharmacokinetic–B Cell Modeling for Ofatumumab i..:

Yu, Huixin ; Graham, Gordon ; David, Olivier J....
CNS Drugs. 36 (2022) 3 - p. 283-300 , 2022

Link: https://doi.org/10.1007/..

3

Treatment Switching and Discontinuation Over 20 Years in th..:

Hillert, Jan ; Magyari, Melinda ; Soelberg Sørensen, Per...
Frontiers in Neurology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

4

Predictors of treatment outcome in patients with paediatric..:

Kopp, Tine Iskov ; Blinkenberg, Morten ; Chalmer, Thor Ameri...
Multiple Sclerosis Journal. 26 (2019) 8 - p. 964-975 , 2019

Link: https://doi.org/10.1177/..

5

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a r..:

on behalf of the MESEMS study group ; Uccelli, Antonio ; Laroni, Alice...
Trials. 20 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

6

Long-term effects of cladribine tablets on MRI activity out..:

Comi, Giancarlo ; Cook, Stuart ; Rammohan, Kottil...
Therapeutic Advances in Neurological Disorders. 11 (2018) - p. 175628561775336 , 2018

Link: https://doi.org/10.1177/..

7

Prognostic value of cerebrospinal fluid neurofilament light..:

Sellebjerg, Finn ; Royen, Lydia ; Soelberg Sørensen, Per..
Multiple Sclerosis Journal. 25 (2018) 11 - p. 1444-1451 , 2018

Link: https://doi.org/10.1177/..

8

Efficacy of Cladribine Tablets in high disease activity sub..:

Giovannoni, Gavin ; Soelberg Sorensen, Per ; Cook, Stuart...
Multiple Sclerosis Journal. 25 (2018) 6 - p. 819-827 , 2018

Link: https://doi.org/10.1177/..

9

Smoking is associated with increased disease activity durin..:

Petersen, Eva Rosa ; Søndergaard, Helle Bach ; Laursen, Julie Hejgaard...
Multiple Sclerosis Journal. 25 (2018) 9 - p. 1298-1305 , 2018

Link: https://doi.org/10.1177/..

10

The Multiple Sclerosis Care Unit:

Soelberg Sorensen, Per ; Giovannoni, Gavin ; Montalban, Xavier...
Multiple Sclerosis Journal. 25 (2018) 5 - p. 627-636 , 2018

Link: https://doi.org/10.1177/..

11

Progressive multiple sclerosis, cognitive function, and qua..:

Højsgaard Chow, Helene ; Schreiber, Karen ; Magyari, Melinda...
Brain and Behavior. 8 (2018) 2 - p. , 2018

Link: https://doi.org/10.1002/..

12

Defining active progressive multiple sclerosis:

Sellebjerg, Finn ; Börnsen, Lars ; Ammitzbøll, Cecilie...
Multiple Sclerosis Journal. 23 (2017) 13 - p. 1727-1735 , 2017

Link: https://doi.org/10.1177/..

13

Clinical practice of analysis of anti-drug antibodies again..:

Link, Jenny ; Ramanujam, Ryan ; Auer, Michael...
PLOS ONE. 12 (2017) 2 - p. e0170395 , 2017

Link: https://doi.org/10.1371/..

14

Evolving concepts in the treatment of relapsing multiple sc..:

Comi, Giancarlo ; Radaelli, Marta ; Soelberg Sørensen, Per
The Lancet. 389 (2017) 10076 - p. 1347-1356 , 2017

Link: https://doi.org/10.1016/..

15

Environmental modifiable risk factors for multiple sclerosi..:

Amato, Maria Pia ; Derfuss, Tobias ; Hemmer, Bernard...
Multiple Sclerosis Journal. 24 (2017) 5 - p. 590-603 , 2017

Link: https://doi.org/10.1177/..